Ignite Creation Date:
2024-05-06 @ 2:00 PM
Last Modification Date:
2024-10-26 @ 1:23 PM
Study NCT ID:
NCT04183335
Status:
COMPLETED
Last Update Posted:
2022-12-12
First Post:
2019-11-27
Brief Title:
Study of Dupilumab for the Treatment of Patients With Prurigo Nodularis Inadequately Controlled on Topical Prescription Therapies or When Those Therapies Are Not Advisable LIBERTY-PN PRIME
Sponsor:
Sanofi
Organization:
Sanofi
Organization Data
Organization:
Sanofi
Class:
INDUSTRY
Study ID:
EFC16459
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Sanofi
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Regeneron Pharmaceuticals | INDUSTRY |